doxorubicin hydrochloride has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bai, C; Chen, J; Chen, Y; Chong, C; Ding, Y; Gao, Y; Geng, Y; Li, J; Wang, M; Wu, L; Yu, J; Zhang, Q | 1 |
Che, Q; Li, D; Li, J; Liu, X; Shah, M; Sun, C; Sun, N; Zhang, G; Zhang, X; Zhu, T | 1 |
1 review(s) available for doxorubicin hydrochloride and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
Cytotoxic Nitrobenzoyl Sesquiterpenoids from an Antarctica Sponge-Derived
Topics: Antarctic Regions; Antineoplastic Agents; Apoptosis; Aspergillus; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Sesquiterpenes | 2022 |
1 other study(ies) available for doxorubicin hydrochloride and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Combinatorial Chemistry Techniques; Humans; Lipopeptides; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides, Cyclic; Structure-Activity Relationship; Tumor Hypoxia | 2018 |